Print Page  |  Contact Us  |  Sign In
Rene Gonzalez, MD
Share |

Dr. Rene Gonzalez is a board-certified internist and medical oncologist. After earning his medical degree from the University of Honduras, Dr. Gonzalez completed his internship and residency at Wayne State University in Detroit, MI and post-doctoral fellowship in medical oncology at the University of Colorado. He joined the faculty at the University of Colorado in 1994 and became director of the Melanoma Research Clinics the same year. This comprehensive program developed into one of the largest in the U.S. and includes multi-disciplinary melanoma clinics and tumor board and basic research. Dr. Gonzalez’s clinical interests are malignant melanoma and other cutaneous malignancies. He is the principal investigator on numerous national and local therapeutic trials. Dr. Gonzalez is a co-chair of COMIRB and a member of several professional societies including the American College of Physicians, the American Society of Clinical Oncology and the Society for Melanoma Research. He is associate editor of Therapeutic Advances in Medical Oncology and on the editorial board of Melanoma Management. He has authored or co-authored several book chapters and more than 100 scientific articles that have been published in peer-reviewed journals. 

Melanoma: The Modern Black Plague

There has been tremendous progress in melanoma therapy in the last 5 years that has revolutionized the field. It is difficult for the practitioner to keep abreast of the new research and place it in context because of rapid change.

Objectives:

  1. Provide attendees with an update on new information and studies
  2. Provide attendees with an update new therapies
  3. Provide attendees with new detection techniques

Needs:

  1. Development of new technology
  2. Advances in medical knowledge

Reference:

  • http://www.ncbi.nlm.nih.gov/pubmed/27059193
  • http://www.ncbi.nlm.nih.gov/pubmed/26811525
  • http:/www.ncbi.nlm.nih.gov/pubmed/26027431

Core Competencies: 2, 3, 5, 6

Disclosures: Research grants: Roche/Genentech, Novartis, BMS, Merck, Amgen, Polynoma, Millennium, Takeda, Incyte, Reata, Dynavax, Checkmate, Morphotek, Castle Bioscience; Consultant for: Roche/Genentech, Novartis, Amgen, Castle Bioscience; Off-label: Unapproved uses of various drugs

Community Search
Sign In


Forgot your password?

Haven't registered yet?

Calendar
Latest News